Welcome to our dedicated page for OMNICELL SEC filings (Ticker: OMCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OMNICELL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OMNICELL's regulatory disclosures and financial reporting.
Omnicell, Inc. executive Corey J. Manley reported share dispositions. He sold 4,243 shares of common stock in an open-market transaction at an exact price of $36.59 per share under a Rule 10b5-1 trading plan adopted on June 13, 2025.
Separately, 2,022 shares were withheld to cover taxes due on the vesting of restricted stock units, which is a tax-withholding disposition rather than an open-market sale. After these transactions and the purchase of 87.3392 shares under the Employee Stock Purchase Plan on February 15, 2026, he directly owned 85,496.3392 shares.
OMNICELL, INC. Chairman, President and CEO Randall A. Lipps reported a tax-withholding disposition of 5,294 shares of common stock on February 15, 2026. The shares were withheld at a price of $36.50 per share to cover taxes due on vesting restricted stock units.
After this transaction, Mr. Lipps directly owned 380,740.0741 shares of Omnicell common stock. He also reported indirect holdings of 355,861 shares held in trust with his wife and 8,051 shares held in trust for the benefit of his children.
Omnicell insider Corey Manley filed a notice to sell common stock under Rule 144. The filing covers 4,243 common shares to be sold through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $155,251.37, and an approximate sale date of February 17, 2026.
The shares were acquired on February 15, 2026 through restricted stock vesting as compensation from the issuer. The notice also lists prior sales over the past three months, including multiple common stock transactions by Manley with disclosed share counts and gross proceeds, showing an ongoing program of share dispositions.
Omnicell, Inc. filed a current report stating it issued a press release on February 5, 2026 announcing its financial results for the quarter and year ended December 31, 2025. The press release is provided as Exhibit 99.1 and is furnished, rather than filed, under securities laws.
Omnicell executive Corey J. Manley, EVP & Chief Legal/Admin Officer, sold 6,106 shares of Omnicell common stock on January 8, 2026. The sale was executed at an exact price of $49.90 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025, which is designed to allow insiders to sell stock according to preset instructions. After this transaction, Manley beneficially owned 91,674 shares of Omnicell common stock directly.
Omnicell insider Corey Manley has filed a Form 144 notice to sell up to 6,106 shares of Omnicell common stock through Fidelity Brokerage Services on NASDAQ, with an indicated aggregate market value of $304,689.40. The planned sale involves common shares, while Omnicell had 44,876,522 shares of common stock outstanding; this is a baseline figure, not the amount being sold.
The shares to be sold were acquired mainly through restricted stock vesting and an employee stock purchase plan between December 2023 and March 2025, including grants of 3,590 shares on March 1, 2025 and 1,370 shares on August 15, 2024. Over the prior three months before this notice, Manley sold 3,473, 6,106, and 278 shares of Omnicell common stock in separate transactions, receiving gross proceeds of $121,207.70, $243,629.40, and $12,037.40, respectively.
Omnicell, Inc.'s Executive Vice President and Chief Legal/Administrative Officer reported routine share movements. On December 15, 2025, 224 shares of common stock were withheld to cover taxes due on the vesting of restricted stock units. On December 16, 2025, the executive sold 278 shares of Omnicell common stock at an exact price of $43.30 per share.
The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2025, which is designed to allow insiders to sell shares according to a preset schedule. After these transactions, the executive beneficially owned 97,780 shares of Omnicell common stock, all held directly.
Omnicell, Inc. reported an insider equity transaction by its Chairman, President and CEO and director, Randall Lipps. On 12/15/2025, the company withheld 1,147 shares of common stock at $43.27 per share to cover taxes due upon the vesting of restricted stock units, which is a non-open-market transaction. After this tax withholding, Mr. Lipps beneficially owned 385,501 shares of Omnicell common stock directly, plus 355,861 shares held in a trust with his wife and 8,051 shares held in trust for the benefit of his children.
Omnicell, Inc. (OMCL) executive Brian H. Nutt, the VP and Chief Accounting Officer, reported a small insider transaction on Form 4. The filing shows that 226 shares of common stock were withheld to cover taxes due in connection with the vesting of restricted stock units at a price of $35.12 per share. After this tax withholding, Nutt directly owns 17,342 shares of Omnicell common stock. This is an administrative equity event tied to compensation rather than an open‑market buy or sell.
Omnicell, Inc. reported an insider share disposition by its Chairman, President and CEO, Randall A. Lipps. On 11/15/2025, Lipps disposed of 8,437 shares of Omnicell common stock at a price of $35.12 per share, coded as an "F" transaction, which indicates shares were withheld to cover taxes related to vesting restricted stock units. Following this transaction, he directly owned 386,648 shares. He also held 355,861 shares in a trust with his wife and 8,051 shares in a trust for the benefit of his children.